Authors



Dr. Reddy Gottipolu

Latest:

Securing the Pharmaceutical Supply Chain with Full Traceability

End-to-end traceability can provide more value than just securing drug product safety.



















David Phillips

Latest:

Minimizing Contamination During BioPharm R&D

The right approach to biological safety cabinets, and collaboration between engineers and those who will operate the equipment, is crucial to preventing cell-culture contamination.


Paul Orange

Latest:

Good Automation Practices in the Laboratory

Laboratory automation can reduce the need for in-lab user presence but requires efficient and dependable user-system interface.


Joe Willmot

Latest:

Good Automation Practices in the Laboratory

Laboratory automation can reduce the need for in-lab user presence but requires efficient and dependable user-system interface.


Dominic Hyde

Latest:

What’s Next in Air Transportation for Clinical Trial Logistics

The future will bring changes for temperature-controlled container rental companies.


Will Fazackerley

Latest:

Good Automation Practices in the Laboratory

Laboratory automation can reduce the need for in-lab user presence but requires efficient and dependable user-system interface.


Andrew James

Latest:

Testing for Nitrosamines in Pharmaceutical Drugs

Recent drug recalls in the United States from nitrosamine contamination prompt the need for more sensitive impurity testing methods and a re-evaluation of acceptable lower limit levels.


Madison Hoal

Latest:

Why Do Disinfectant Residues Matter?

Consider how to assess risks and understand possible sources of disinfectant residues in pharmaceutical manufacturing.


Donald Singer

Latest:

Refining Microbiological Control for Non-Sterile Products

Subsequent guidance and manufacturing realities make portions of USP Chapters <62 >and <111> significantly less relevant. The authors suggest formal chapter revisions.